We are live on ! Find out more
BBHC

Brown Brothers Harriman & Co Portfolio holdings

AUM $18.6B
1-Year Est. Return 15.81%
This Fund
S&P 500
This Quarter Est. Return
+3.84%
1 Year Est. Return
+15.81%
3 Year Est. Return
+66.02%
5 Year Est. Return
+80.97%
10 Year Est. Return
+273.41%
AUM
$24.7B
AUM Growth
+$1.25B
Cap. Flow
+$447M
Cap. Flow %
1.81%
Top 10 Hldgs %
44.26%
Holding
860
New
58
Increased
155
Reduced
173
Closed
111

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$195M
2
NVS icon
Novartis
NVS
+$87.1M
3
BAX icon
Baxter International
BAX
+$7.25M
4
XOM icon
ExxonMobil
XOM
+$6.17M
5
DIS icon
Walt Disney
DIS
+$4.09M

Sector Composition

Rank Sector Weight
1 Financials 24.43%
2 Healthcare 13.63%
3 Energy 13.53%
4 Communication Services 11.7%
5 Consumer Staples 10.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRV icon
101
Travelers Companies
TRV
$80.2B
$6.12M 0.02%
65,104
+1,391
+2% +$127K
KMB icon
102
Kimberly-Clark
KMB
$36.5B
$6.12M 0.02%
57,380
+10,430
+22% +$1.11M
XPO icon
103
XPO
XPO
$23.7B
$6.04M 0.02%
609,674
BAC icon
104
Bank of America
BAC
$442B
$5.92M 0.02%
385,289
-22
-0% -$342
EMR icon
105
Emerson Electric
EMR
$88.3B
$5.79M 0.02%
87,294
-4,239
-5% -$285K
MTD icon
106
Mettler-Toledo International
MTD
$28.6B
$5.71M 0.02%
22,550
-8,076
-26% -$1.94M
BMY icon
107
Bristol-Myers Squibb
BMY
$132B
$5.7M 0.02%
117,540
-7,578
-6% -$373K
GWW icon
108
W.W. Grainger
GWW
$60.2B
$5.43M 0.02%
21,341
-1,236
-5% -$316K
CELG
109
DELISTED
Celgene Corp
CELG
$5.41M 0.02%
63,038
+21,082
+50% +$1.6M
MDY icon
110
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.3B
$5.38M 0.02%
20,646
SM icon
111
SM Energy
SM
$6.87B
$5.23M 0.02%
62,154
ABBV icon
112
AbbVie
ABBV
$435B
$5.11M 0.02%
90,485
-10,676
-11% -$560K
MA icon
113
Mastercard
MA
$493B
$4.78M 0.02%
65,102
+18,886
+41% +$1.4M
MDT icon
114
Medtronic
MDT
$112B
$4.77M 0.02%
74,750
-5,320
-7% -$323K
AGN
115
DELISTED
Allergan Inc
AGN
$4.71M 0.02%
27,847
+7,894
+40% +$1.23M
PNC icon
116
PNC Financial Services
PNC
$101B
$4.57M 0.02%
51,306
-3,890
-7% -$332K
CBT icon
117
Cabot Corp
CBT
$4.52B
$4.57M 0.02%
78,749
-1,506
-2% -$87.7K
ICE icon
118
Intercontinental Exchange
ICE
$84.4B
$4.38M 0.02%
115,790
+41,745
+56% +$1.63M
CSCO icon
119
Cisco
CSCO
$479B
$4.29M 0.02%
172,698
+16,402
+10% +$391K
MCD icon
120
McDonald's
MCD
$195B
$4.13M 0.02%
40,952
-6,918
-14% -$698K
DVA icon
121
DaVita
DVA
$11.7B
$4.1M 0.02%
+56,662
New +$3.94M
BA icon
122
Boeing
BA
$185B
$4.09M 0.02%
32,171
+16,042
+99% +$2.09M
VWO icon
123
Vanguard FTSE Emerging Markets ETF
VWO
$124B
$4.05M 0.02%
93,952
CAT icon
124
Caterpillar
CAT
$387B
$3.88M 0.02%
35,697
-703
-2% -$73.8K
ADBE icon
125
Adobe
ADBE
$105B
$3.75M 0.02%
51,834
+18,761
+57% +$1.21M

Similar funds

Brown Brothers Harriman & Co's Q2 2014 Portfolio in Review

As of Q2 2014, Brown Brothers Harriman & Co held 860 positions worth $24.7B, up 5.3% from $23.4B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Brown Brothers Harriman & Co's Q2 2014 filing shows 58 new, 155 increased, 173 reduced and 111 closed positions. Its largest new stake was Aramark: 374,708 shares worth $7M. The largest sale was Johnson & Johnson, an estimated $195M.

By sector, the portfolio is most concentrated in Financials at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Energy.

  • Brown Brothers Harriman & Co's largest Q2 2014 buy was Aramark: 374,708 shares worth $7M.
  • Brown Brothers Harriman & Co added most to Philip Morris in Q2 2014, an estimated $177M increase.
  • Brown Brothers Harriman & Co's biggest Q2 2014 reduction was Johnson & Johnson, cutting an estimated $195M.
  • Brown Brothers Harriman & Co fully exited Kinder Morgan in Q2 2014, selling an estimated $909K.
  • Brown Brothers Harriman & Co's ten largest holdings make up 44% of its $24.7B portfolio in Q2 2014.
  • Brown Brothers Harriman & Co opened 58 new positions and closed 111 in Q2 2014.
  • Brown Brothers Harriman & Co's portfolio value rose 5.3% quarter-over-quarter to $24.7B.

Based on Brown Brothers Harriman & Co's 13F filing for Q2 2014, filed 15 Aug 2014.